Journal of skin cancer
Oral Nicotinamide for the Secondary Prevention of Cutaneous Squamous Cell Carcinoma and Other Keratinocyte Carcinomas: A Systematic Review
Por Guerra Jiménez AL, Ortegón Garciaherreros JC, Suárez Escobar LP y 2 más.
Contenido en inglés
Resumen
Background
Oral nicotinamide has been proposed as a chemoprevention strategy to reduce new keratinocyte carcinomas in people with a history of skin cancer, but its effect may differ between immunocompetent patients and transplant recipients.